| Name | Title | Contact Details |
|---|
CARTI is a multi-disciplinary cancer care provider with locations throughout Arkansas. Providing medical, radiation, interventional and surgical oncology, as well as diagnostic radiology, CARTI cares for more than 20,000 cancer patients each year.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Visiting Nurse Association of Tulsa is a Tulsa, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Dynamic Medical Systems is a recognized leader in providing products and services for the healthcare industry.
Atlantic Anesthesia is a Virginia Beach, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.